Recombinant Human IGFBP-2

Recombinant Human IGFBP-2 is widely used in research because it is a key modulator of insulin-like growth factor (IGF) signaling, with both IGF-dependent and IGF-independent roles in cell biology, cancer, and development. Using recombinant IGFBP-2 allows for controlled, reproducible studies of its molecular functions and biological effects.

Key reasons to use recombinant human IGFBP-2 in research applications:

• IGF Modulation: IGFBP-2 binds IGF-I and IGF-II, regulating their bioavailability and activity, which is crucial for studying cell proliferation, differentiation, and survival in various physiological and pathological contexts.
• Cancer Biology: IGFBP-2 is implicated in tumorigenesis, acting as a survival factor in some cancers (e.g., breast cancer) by enhancing DNA repair and promoting resistance to chemotherapy. In other contexts, it may act as a tumor suppressor by inhibiting cell growth and invasion.
• IGF-Independent Effects: IGFBP-2 also exerts IGF-independent actions, such as modulating intracellular signaling pathways (e.g., integrin/ERK signaling), influencing cell migration, invasion, and chemoresistance, particularly in glioma and other cancer models.
• Developmental Studies: IGFBP-2 is highly expressed during embryonic and fetal development, making it valuable for research on developmental biology and tissue differentiation.
• Protein Engineering and Structural Studies: Recombinant IGFBP-2 produced in systems like E. coli is suitable for structural and functional analyses, enabling the generation of engineered variants for mechanistic studies or therapeutic development.
• Assay Standardization: Recombinant IGFBP-2 is used as a standard in immunoassays (e.g., ELISA) and for spike-and-recovery experiments, ensuring assay reliability and reproducibility.
• Protein-Protein Interaction Studies: It is used in binding assays to investigate interactions with IGFs, integrins, proteoglycans, and other cell surface receptors.

Summary of applications:

• Cell signaling and mechanistic studies
• Cancer research (proliferation, invasion, chemoresistance)
• Developmental biology
• Structural biology and protein engineering
• Immunoassay calibration and validation
• Protein-protein interaction assays

Using recombinant human IGFBP-2 provides a consistent, well-characterized reagent for dissecting its diverse biological roles and for developing potential therapeutic strategies targeting IGF signaling pathways.

Recombinant Human IGFBP-2 can be used as a standard for quantification or calibration in ELISA assays, provided it is well-characterized and compatible with your assay system. Recombinant IGFBP-2 is commonly used as a calibrator in commercial ELISA kits, and its standard curves are validated to be parallel to those generated with natural human IGFBP-2, ensuring accurate quantification.

Key considerations and best practices:

• Assay Compatibility: Most sandwich ELISA kits for IGFBP-2 use recombinant human IGFBP-2 as the standard, and these kits are validated to quantify both recombinant and natural forms of the protein. The standard curve generated with recombinant IGFBP-2 allows interpolation of sample concentrations, assuming the recombinant protein is structurally and immunologically similar to the endogenous protein.

• Validation: It is important to confirm that the recombinant IGFBP-2 you use is recognized by the antibodies in your ELISA system. Commercial kits typically provide recombinant IGFBP-2 standards that have been validated for parallelism with natural IGFBP-2, meaning the assay quantifies both forms equivalently. If you are developing your own assay, you should verify parallelism by comparing dilution curves of recombinant and natural IGFBP-2.

• Standard Preparation: Prepare the recombinant IGFBP-2 standard according to the manufacturer's instructions or your validated protocol, ensuring accurate concentration and proper diluent. Use duplicate or triplicate wells for each standard concentration to improve precision.

• Curve Fitting: Use appropriate curve fitting methods (e.g., 4-parameter logistic, 4PL) to generate the standard curve, as recommended for quantitative ELISA assays.

• Limitations: Some ELISA kits are designed specifically for native IGFBP-2 and may not detect recombinant forms if there are significant structural differences. Always check the kit documentation for compatibility.

Summary Table: Use of Recombinant IGFBP-2 as ELISA Standard

In conclusion, recombinant human IGFBP-2 is widely accepted as a standard for ELISA quantification, provided it is validated for your specific assay system and the antibodies used recognize both recombinant and natural forms equivalently.

Recombinant Human IGFBP-2 has been validated for a diverse range of applications in published research, primarily in studies of cell signaling, cancer biology, metabolic regulation, and protein interaction assays.

Key validated applications include:

• Bioassays: Used to measure its ability to inhibit the biological activity of IGF-I or IGF-II, particularly in cell-based assays such as those involving MCF-7 human breast cancer cells. Also applied in ex vivo expansion of hematopoietic stem and progenitor cells.

• Enzyme Assays: Utilized to study proteolytic degradation (e.g., by matrix metalloproteinase-7) and to assess IGFBP-2’s impact on IGF bioavailability.

• Binding Assays / Protein-Protein Interaction: Employed to confirm IGFBP-2’s binding to IGF-1 and IGF-2, and to investigate protein-protein interactions relevant to IGF signaling.

• Immunoassay Standard: Used as a spike-and-recovery control in plasma for ELISA-based quantification of IGFBP-2.

• Western Blot: Validated for detection and quantification of IGFBP-2 in recombinant protein samples.

• Cellular Bioactivity Assays: Applied in in vitro cell culture to assess effects on cell proliferation, invasion, and chemoresistance, especially in cancer cell lines such as glioma and hepatocellular carcinoma.

• Structural Studies: Recombinant IGFBP-2 produced in E. coli has been used for high-yield expression and structural characterization via NMR and X-ray crystallography, supporting structure-function analyses and therapeutic development.

• Metabolic and Disease Models: Used in studies investigating its role in obesity, insulin resistance, metabolic syndrome, and autoimmune diseases, often as a biomarker or functional modulator.

Additional validated uses include:

• Immunofluorescence: For localization studies of IGFBP-2 and downstream signaling molecules (e.g., ERK phosphorylation in glioblastoma cells).
• Cell Cycle Analysis and Migration Assays: To assess IGFBP-2’s impact on cell proliferation and invasion.

Summary Table of Validated Applications

These applications demonstrate the versatility of recombinant human IGFBP-2 in both basic and translational research, particularly in the fields of oncology, endocrinology, and immunology.

Reconstitution of Recombinant Human IGFBP-2

Recombinant human IGFBP-2 is typically supplied as a lyophilized powder that requires reconstitution before use in cell culture experiments. The protein is a 31.5 kDa molecule consisting of 289 amino acid residues and contains multiple conserved cysteines that require careful handling to maintain proper disulfide bonding patterns.

Reconstitution Protocol

Reconstitution Medium

The standard approach is to reconstitute the lyophilized protein in sterile PBS (phosphate-buffered saline) at pH 7.4 or sterile distilled water. Some protocols recommend adding 5-50% glycerol as a final concentration to enhance protein stability during storage.

Reconstitution Concentration

Reconstitute the protein to a working concentration of 0.1-1.0 mg/mL. A common standard concentration used in assays is 100 μg/mL in sterile PBS.

Reconstitution Procedure

• Do not vortex the reconstituted protein, as this can cause denaturation and aggregation
• Mix gently by pipetting up and down to ensure thorough dissolution
• Allow the reconstituted solution to sit at room temperature for approximately 10 minutes with gentle mixing to ensure complete hydration

Storage and Stability

After reconstitution, proper storage is critical for maintaining protein integrity:

Important Storage Guidelines

• Use a manual defrost freezer to avoid temperature fluctuations
• Avoid repeated freeze-thaw cycles, as these can compromise protein structure and function
• If frozen samples require thawing, thaw completely and mix gently (without vortexing) prior to use
• Store unopened lyophilized protein at ambient temperature until use, then immediately transfer reconstituted material to appropriate storage conditions

Preparation for Cell Culture Experiments

Sample Handling

When using IGFBP-2 in cell culture experiments, maintain sterile conditions throughout preparation. The protein can be diluted into serum-free medium (SFM) for direct addition to cell cultures. For dose-response studies, prepare serial dilutions in the appropriate culture medium immediately before use.

Quality Considerations

The recombinant protein should be obtained with high purity (>95% is achievable through proper expression and purification protocols). The protein exists as a monomer at physiological concentrations and maintains a unique intra-molecular disulfide-bonding pattern essential for its biological activity in binding insulin-like growth factors.